Shopping Cart 0
Cart Subtotal
USD 0

Weill Cornell Medical College - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Weill Cornell Medical College (Weill Cornell), a subsidiary of Cornell University is a medical institute that offers education, research and patient care services. The institute offers degrees in medicine and Ph.D. programs in biomedical research. It operates with various basic sciences and patient care departments including anesthesiology, biochemistry, pharmacology, pediatrics, cardiology, radiology, medicine, orthopedic surgery, obstetrics and gynecology and genetic medicine, among others. Weill Cornell operates research centers and institutes for aging research and clinical care; computational biomedicine; vascular biology; women's health; geriatric psychiatry; and others. Weill Cornell is headquartered in New York, the US.

Weill Cornell Medical College-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Weill Cornell Medical College, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Nanobiotix Enters into Research Collaboration with Weill Cornell Medical 10

Boehringer Ingelheim Enters into Agreement with Weill Cornell Medicine 11

Janssen Biotech Partners with Weill Cornell Medicine to Develop Prostate Cancer Therapies 12

MeiraGTx Enters into Agreement with Weill Cornell Medicine 13

MeiraGTx Enters into Agreement with Weill Cornell Medicine and LSU Health Shreveport 14

Senior Scientific Enters into Research Agreement with Weill Cornell Medicine 15

Weill Cornell Medical Enters into Research Agreement with Cellectis 16

Weill Cornell Medical College Enters into Co-Development Agreement with Janssen Biotech and Johnson & Johnson Innovation 17

Weill Cornell Medical College Enters Into Research Agreement With UCB For Drug Discovery Projects 18

Immunovaccine Enters Into Co-Development Agreement With Weill Cornell Medical College For Anti-Cocaine Vaccine 19

Licensing Agreements 20

Annapurna Therapeutics Enters into Licensing Agreement with Weill Cornell Medicine 20

Angiocrine Bioscience Enters into Licensing Agreement with Weill Cornell Medical College 21

Weill Cornell Medical College-Key Competitors 22

Weill Cornell Medical College-Key Employees 23

Weill Cornell Medical College-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Joint Venture 25

Recent Developments 26

Government and Public Interest 26

Jul 09, 2018: Gene Mutations Predicting Blood Cancer Risk Detectable a Decade Before Diagnosis 26

Feb 05, 2018: American Diabetes Association Awards USD 9.75 million to Six Leading Researchers for the 2018 Pathway to Stop Diabetes Research Grants 28

Jan 29, 2018: Weill Cornell Medicine Joins TriNetX Health Research Network to Expand Breadth of Clinical Research 30

Nov 02, 2017: Lung Cancer Research Foundation Awards USD 1.6 Million in Research Grants 31

May 17, 2017: Weill Cornell team creates self-renewing hematopoietic stem cells for transplantation 33

Apr 28, 2017: WorldQuant Initiative for Quantitative Prediction Established at Weill Cornell Medicine 35

Apr 28, 2017: Immune Cells Play Crucial Role in Brain Cancer Development 37

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39


List Of Figure

List of Figures

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Key Facts 2

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Weill Cornell Medical College, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Weill Cornell Medical College, Deals By Therapy Area, 2012 to YTD 2018 8

Weill Cornell Medical College, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Nanobiotix Enters into Research Collaboration with Weill Cornell Medical 10

Boehringer Ingelheim Enters into Agreement with Weill Cornell Medicine 11

Janssen Biotech Partners with Weill Cornell Medicine to Develop Prostate Cancer Therapies 12

MeiraGTx Enters into Agreement with Weill Cornell Medicine 13

MeiraGTx Enters into Agreement with Weill Cornell Medicine and LSU Health Shreveport 14

Senior Scientific Enters into Research Agreement with Weill Cornell Medicine 15

Weill Cornell Medical Enters into Research Agreement with Cellectis 16

Weill Cornell Medical College Enters into Co-Development Agreement with Janssen Biotech and Johnson & Johnson Innovation 17

Weill Cornell Medical College Enters Into Research Agreement With UCB For Drug Discovery Projects 18

Immunovaccine Enters Into Co-Development Agreement With Weill Cornell Medical College For Anti-Cocaine Vaccine 19

Annapurna Therapeutics Enters into Licensing Agreement with Weill Cornell Medicine 20

Angiocrine Bioscience Enters into Licensing Agreement with Weill Cornell Medical College 21

Weill Cornell Medical College, Key Competitors 22

Weill Cornell Medical College, Key Employees 23

Weill Cornell Medical College, Subsidiaries 25

Weill Cornell Medical College, Joint Venture 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Weill Cornell Medical College, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.